about
Gliomas and the vascular fragility of the blood brain barrierIbrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma.Tenascin-C is expressed by human glioma in vivo and shows a strong association with tumor blood vessels.Intratumoral decorin gene delivery by AAV vector inhibits brain glioblastomas and prolongs survival of animals by inducing cell differentiation.Expression Analysis of Genes Involved in the RB/E2F Pathway in Astrocytic Tumors.Human Cytomegalovirus DNA Quantification and Gene Expression in Gliomas of Different Grades.MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas.IQGAP1 in Podosomes/Invadosomes Is Involved in the Progression of Glioblastoma Multiforme Depending on the Tumor Status.Diagnosis of oligodendroglioma: molecular and classical histological assessment in the twenty-first century.Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach.Role of tenascins in the ECM of gliomas.Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis.Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach.The Na, K-ATPase β-Subunit Isoforms Expression in Glioblastoma Multiforme: Moonlighting Roles.LOH on 10p14-p15 targets the PFKFB3 gene locus in human glioblastomas.SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation.In vitro evaluation of the cytotoxicity and cellular uptake of CMCht/PAMAM dendrimer nanoparticles by glioblastoma cell models
P2860
Q28081953-7973137F-4E3D-45A4-B3CD-312A03F64085Q33909648-57B72962-122F-4E1B-8545-6E364014F9D2Q34959853-6B9C750B-55E9-4C6E-B78B-1FC27A5C8AB5Q35119851-8EFF7DE7-FA0E-430B-BD55-950BBF1D6CD7Q35758932-30C7973C-AA0A-47BD-9DAB-B7CC09D816F2Q36085755-0F8F9C5C-778F-483F-B79C-5C32B65965A5Q37492137-86F73A8B-6622-49D8-B0DD-A6E3A02FCDC5Q37564738-2AD025F0-F77D-4F74-80E7-B0E050EC0DA9Q37631605-881735D5-815C-487F-BF5E-1F9C6662CB10Q38035066-A44EAD63-DFC7-4901-9CF7-48F2A4EA4456Q38108186-15593D37-DFAC-4F15-B796-41FEC5640A2EQ38361238-64286EC8-269A-416A-B8A2-812149D8CB8DQ39253754-852CF490-7A75-4095-8A28-DADD4CE66BD8Q40993120-026EA255-6850-458F-98E8-6804690A8EC4Q47148645-B89CAE5F-15C3-4D71-8C10-3A205CABBDA1Q48851931-59B1695D-374E-4A48-AEC1-869A1FC435A2Q54372505-88F1F5B2-CDC3-44F9-AA8D-F36CDE5358FEQ57171272-AB1A44FE-6AE2-4854-8FF6-5F99C15B7CE8
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular neuropathology of gliomas.
@en
Molecular neuropathology of gliomas.
@nl
type
label
Molecular neuropathology of gliomas.
@en
Molecular neuropathology of gliomas.
@nl
prefLabel
Molecular neuropathology of gliomas.
@en
Molecular neuropathology of gliomas.
@nl
P2860
P921
P356
P1476
Molecular neuropathology of gliomas.
@en
P2093
Markus J Riemenschneider
P2860
P304
P356
10.3390/IJMS10010184
P407
P5008
P577
2009-01-01T00:00:00Z
2009-01-07T00:00:00Z